C-RAD AB – Interim report January-September 2018
Press release 2018-10-26 C-RAD REPORTS ALL-TIME HIGH IN QUARTELY ORDER INTAKE THIRD QUARTER 2018 · Order intake: 64.2 (55.5) MSEK, 16%. · Revenues: 46.7 (33.2) MSEK, 41%. · Operating profit: 0.4 (-1.4) MSEK. · Net results after tax: 0.3 (-1.7) MSEK · Result per share: 0.01 (-0.05) SEK. · Sahlgrenska University Hospital selects C-RAD’s innovative SIGRT solution.Order value: 8.5 MSEK. · MedAustron, the first Ion-therapy treatment site in Austria, selected C-RAD Catalyst PT. Order value: 4.9 MSEK. Comments from Tim Thurn, CEO: SUBSTANTIAL PROGRESS ON